Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301986 · ClinicalTrials.gov registry record · NA
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04301986 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 24 participants.
The verdict
NCT04301986, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To assess patient acceptance and preference among screening modalities, Esophagogastroduodenoscopy (EGD), Transnasal Esophagoscopy (TNE), and Cytosponge for Barrett's esophagus (BE). Subjects will undergo administration of Cytosponge and transnasal endoscopy (TNE) prior to their scheduled clinically indicated upper endoscopy performed per routine standard of care. Following the procedure, a follow-up phone call will be made during which an impact of events scale related to the subjective distress of each procedure, a preference and acceptance questionnaire, and adverse events related to study participation will be collected.
Interventions
- DEVICE Cytosponge
- DEVICE Transnasal Endoscopy (TNE)
- DEVICE Esophagogastroduodenoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-08-11 |
| Est. Completion | 2022-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04301986
The ClinicalTrials.gov registry entry for NCT04301986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cytosponge is the first listed.
NCT04301986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04301986 about?
NCT04301986 is a clinical study titled "Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus". To assess patient acceptance and preference among screening modalities, Esophagogastroduodenoscopy (EGD), Transnasal Esophagoscopy (TNE), and Cytosponge for Barrett's esophagus (BE). Subjects will undergo administration of Cytosponge and transnasal endoscopy (TNE) prior to their scheduled clinically...
What is the current status of trial NCT04301986?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-08-11. Estimated completion is 2022-05-10.
What interventions are being tested in trial NCT04301986?
The interventions under investigation include: Cytosponge (DEVICE), Transnasal Endoscopy (TNE) (DEVICE), Esophagogastroduodenoscopy (DEVICE).
Who is sponsoring clinical trial NCT04301986?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.